Education
About Us
Working with TipRanks
Follow Us
Sundrug Co Ltd (JP:9989)
:9989
Total Valuation
Sundrug Co has a market cap or net worth of $516.10B. The enterprise value is ¥466.01B.
Market Cap$516.10B
Enterprise Value¥466.01B
Share Statistics
Sundrug Co has 119,331,184 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding119,331,184
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sundrug Co’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 9.81%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)9.81%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee120.36M
Profits Per Employee4.62M
Employee Count6,662
Asset Turnover1.81
Inventory Turnover6.06
Valuation Ratios
The current PE Ratio of Sundrug Co is 16.01. Sundrug Co’s PEG ratio is 2.88.
PE Ratio16.01
PS Ratio0.00
PB Ratio1.83
Price to Fair Value1.83
Price to FCF63.83
Price to Operating Cash Flow11.96
PEG Ratio2.88
Income Statement
In the last 12 months, Sundrug Co had revenue of 801.81B and earned 30.75B in profits. Earnings per share was 262.90.
Revenue801.81B
Gross Profit204.09B
Operating Income44.50B
Pretax Income43.57B
Net Income30.75B
EBITDA61.02B
Earnings Per Share (EPS)262.90
Cash Flow
In the last 12 months, operating cash flow was 8.89B and capital expenditures -8.32B, giving a free cash flow of 571.00M billion.
Operating Cash Flow8.89B
Free Cash Flow571.00M
Free Cash Flow per Share4.79
Dividends & Yields
Sundrug Co pays an annual dividend of ¥65, resulting in a dividend yield of 2.83%
Dividend Per Share¥65
Dividend Yield2.83%
Payout Ratio24.72%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.38
52-Week Price Change17.48%
50-Day Moving Average4.53K
200-Day Moving Average4.10K
Relative Strength Index (RSI)40.10
Average Volume (3m)393.03K
Important Dates
Sundrug Co upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 15, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
Sundrug Co as a current ratio of 1.69, with Debt / Equity ratio of 14.34%
Current Ratio1.69
Quick Ratio0.92
Debt to Market Cap0.08
Net Debt to EBITDA-0.43
Interest Coverage Ratio271.32
Taxes
In the past 12 months, Sundrug Co has paid 12.82B in taxes.
Income Tax12.82B
Effective Tax Rate0.29
Enterprise Valuation
Sundrug Co EV to EBITDA ratio is 7.64, with an EV/FCF ratio of 60.42.
EV to Sales0.58
EV to EBITDA7.64
EV to Free Cash Flow60.42
EV to Operating Cash Flow11.32
Balance Sheet
Sundrug Co has $60.13B in cash and marketable securities with ¥33.54B in debt, giving a net cash position of -$26.59B billion.
Cash & Marketable Securities$60.13B
Total Debt¥33.54B
Net Cash-$26.59B
Net Cash Per Share-$222.78
Tangible Book Value Per Share$2.23K
Margins
Gross margin is 25.45%, with operating margin of 5.55%, and net profit margin of 3.84%.
Gross Margin25.45%
Operating Margin5.55%
Pretax Margin5.43%
Net Profit Margin3.84%
EBITDA Margin7.61%
EBIT Margin5.45%
Analyst Forecast
The average price target for Sundrug Co is $5,049.36, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5,049.36
Price Target Upside14.19% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast6.66%
EPS Growth Forecast5.56%